<DOC>
	<DOC>NCT01141270</DOC>
	<brief_summary>Comparative pharmacokinetics study after single subcutaneous application of AFOLIA and the reference product (Gonal-f®). Objective: To demonstrate equivalence within the 80%-125% margin of the reference product for the area under the curve (AUC) of AFOLIA compared to (Gonal-f®).</brief_summary>
	<brief_title>Comparative Pharmacokinetics of AFOLIA and Gonal-f® After Single Subcutaneous Application</brief_title>
	<detailed_description />
	<criteria>Healthy female volunteers Age between 1838 years Body mass index 1729 kg/m2 Woman of child bearing potential must agree to practice effective barrier methods for birth control Use of oral contraceptives for at least 3 months before study entry Regular menstruation cycle (2534 days) before initiation of oral contraception Presence of both ovaries Normal findings in medical history and physical and gynaecological examination unless the investigator considers an abnormality to be clinically irrelevant for this study Signed informed consent Polycystic ovary syndrome (PCOS) History of hypersensitivity to FSH (Ovary Hyperstimulation Syndrome, OHSS) Impaired thyroid function (treated or untreated) History of malignant disease AST and/or ALAT &gt; 2 x ULN Other clinically relevant findings (ECG, blood pressure, physical, gynecological examination, laboratory examination) Smoking habits of more than 5 cigarettes per day Abuse of alcoholic beverages and drugs Participation in a clinical trial within 3 weeks prior to the study Foreseen inability to attend to scheduled study visits Symptoms of a clinically relevant illness during 3 weeks prior the first study day Pregnancy or lactation period Any medical condition that, in the opinion of the investigator, would interfere with safety of the subject or interference of the objectives of the study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>38 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>recombinant human follicle stimulating hormone</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>bioequivalence</keyword>
</DOC>